Literature DB >> 22678357

Does long-term medication use improve the academic outcomes of youth with attention-deficit/hyperactivity disorder?

Joshua M Langberg1, Stephen P Becker.   

Abstract

Youth with Attention-Deficit/Hyperactivity Disorder (ADHD) frequently experience academic impairment, including lower grades than their peers and elevated risk for grade retention and school dropout. Medication is the most commonly used treatment for youth with ADHD, and it is therefore essential to understand the extent to which medication use improves long-term academic functioning. This paper reviews the literature on the relation between long-term medication use and the academic outcomes of youth with ADHD. A systematic literature search was conducted to identify pertinent studies published since 2000 that followed youth with ADHD for 3 or more years. Academic outcomes of interest included school grades, achievement test scores, and grade retention. Nine studies were identified reporting on eight distinct longitudinal samples (N across studies = 8,721). These studies demonstrate that long-term medication use is associated with improvements in standardized achievement scores. However, the magnitude of these improvements is small and the clinical or educational significance is questionable. Evidence for long-term improvements in school grades and grade retention is less compelling. This review highlights methodological considerations in providing directions for future research. The importance of using multiple sources to gather information about medication adherence is discussed, including use of methodologies such as electronic monitors, rather than relying solely on parent report or chart review. Future research should also examine a range of medication adherence definitions in order to determine whether age of onset, duration of use, dose, and/or consistency of use moderates the relation between long-term medication use and academic outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22678357     DOI: 10.1007/s10567-012-0117-8

Source DB:  PubMed          Journal:  Clin Child Fam Psychol Rev        ISSN: 1096-4037


  49 in total

Review 1.  College students with ADHD and other hidden disabilities. Outcomes and interventions.

Authors:  L E Wolf
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

Review 2.  Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance.

Authors:  S Hack; B Chow
Journal:  J Child Adolesc Psychopharmacol       Date:  2001       Impact factor: 2.576

3.  The importance of ADHD subtype classification for educational applications of DSM-V.

Authors:  Lucy Barnard; Tara Stevens; Yen M To; William Y Lan; Miriam Mulsow
Journal:  J Atten Disord       Date:  2009-04-16       Impact factor: 3.256

Review 4.  Do stimulant drugs improve the academic performance of hyperkinetic children? A review of outcome studies.

Authors:  R A Barkley; C E Cunningham
Journal:  Clin Pediatr (Phila)       Date:  1978-01       Impact factor: 1.168

5.  Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-09-02       Impact factor: 17.586

6.  Executive impairment determines ADHD medication response: implications for academic achievement.

Authors:  James B Hale; Linda A Reddy; Margaret Semrud-Clikeman; Lisa A Hain; James Whitaker; Jessica Morley; Kyle Lawrence; Alex Smith; Nicole Jones
Journal:  J Learn Disabil       Date:  2011 Mar-Apr

7.  Attention-deficit/hyperactivity disorder outcomes for children treated in community-based pediatric settings.

Authors:  Jeffery N Epstein; Joshua M Langberg; Philip K Lichtenstein; Mekibib Altaye; William B Brinkman; Katherine House; Lori J Stark
Journal:  Arch Pediatr Adolesc Med       Date:  2010-02

8.  Academic achievement over 8 years among children who met modified criteria for attention-deficit/hyperactivity disorder at 4-6 years of age.

Authors:  Greta M Massetti; Benjamin B Lahey; William E Pelham; Jan Loney; Ashley Ehrhardt; Steve S Lee; Heidi Kipp
Journal:  J Abnorm Child Psychol       Date:  2007-10-17

9.  The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.

Authors:  Brooke S G Molina; Stephen P Hinshaw; James M Swanson; L Eugene Arnold; Benedetto Vitiello; Peter S Jensen; Jeffery N Epstein; Betsy Hoza; Lily Hechtman; Howard B Abikoff; Glen R Elliott; Laurence L Greenhill; Jeffrey H Newcorn; Karen C Wells; Timothy Wigal; Robert D Gibbons; Kwan Hur; Patricia R Houck
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-05       Impact factor: 8.829

10.  Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.

Authors:  Lily Hechtman; Howard Abikoff; Rachel G Klein; Gabrielle Weiss; Chara Respitz; Joan Kouri; Carol Blum; Brian Greenfield; Joy Etcovitch; Karen Fleiss; Simcha Pollack
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-07       Impact factor: 8.829

View more
  39 in total

Review 1.  Advancing Evidence-Based Assessment in School Mental Health: Key Priorities for an Applied Research Agenda.

Authors:  Prerna G Arora; Elizabeth H Connors; Melissa W George; Aaron R Lyon; Courtney B Wolk; Mark D Weist
Journal:  Clin Child Fam Psychol Rev       Date:  2016-12

2.  Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Authors:  Tanya E Froehlich; Jason Fogler; William J Barbaresi; Nada A Elsayed; Steven W Evans; Eugenia Chan
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

3.  Attention-Deficit/Hyperactivity Disorder, School Performance, and Effect of Medication.

Authors:  Andreas Jangmo; Amanda Stålhandske; Zheng Chang; Qi Chen; Catarina Almqvist; Inna Feldman; Cynthia M Bulik; Paul Lichtenstein; Brian D'Onofrio; Ralf Kuja-Halkola; Henrik Larsson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-02-02       Impact factor: 8.829

Review 4.  Improving outcomes for youth with ADHD: a conceptual framework for combined neurocognitive and skill-based treatment approaches.

Authors:  Anil Chacko; Michael Kofler; Matthew Jarrett
Journal:  Clin Child Fam Psychol Rev       Date:  2014-12

5.  Mediators of methylphenidate effects on math performance in children with attention-deficit hyperactivity disorder.

Authors:  Tanya E Froehlich; Tanya N Antonini; William B Brinkman; Joshua M Langberg; John O Simon; Ryan Adams; Bridget Fredstrom; Megan E Narad; Kathleen M Kingery; Mekibib Altaye; Heather Matheson; Leanne Tamm; Jeffery N Epstein
Journal:  J Dev Behav Pediatr       Date:  2014 Feb-Mar       Impact factor: 2.225

6.  Medication: the smart-pill oversell.

Authors:  Katherine Sharpe
Journal:  Nature       Date:  2014-02-13       Impact factor: 49.962

7.  Attention deficit hyperactivity disorder: clinical update.

Authors:  Geoff Kewley; Natasha Halliwell
Journal:  Br J Gen Pract       Date:  2014-04       Impact factor: 5.386

8.  The relationship between ADHD symptom dimensions, clinical correlates, and functional impairments.

Authors:  Annie A Garner; Briannon C Oʼconnor; Megan E Narad; Leanne Tamm; John Simon; Jeffery N Epstein
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

9.  Attention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in Children.

Authors:  Sarah A Orban; Tanya A Karamchandani; Leanne Tamm; Craig A Sidol; James Peugh; Tanya E Froehlich; William B Brinkman; Nicole Estell; Akemi E Mii; Jeffery N Epstein
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-08-27       Impact factor: 2.576

Review 10.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.